Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06893770

The Effect of the Quran on Quality of Life and Quality of Sleep in Breast Cancer

Objective: This study aims to investigate the effects of Quran on quality of life and sleep in patients receiving chemotherapy due to breast cancer.

Method: This study will be conducted with 40 patients with breast cancer receiving chemotherapy at Erzurum City Hospital Outpatient Chemotherapy Unit in a randomized controlled experimental design. Block randomization will be used in group assignment. The breast cancer patient identification form, European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Scale (QLQ-C30) and Pittsburg Sleep Quality Index (PSQI) will be used to collect research data. It is planned to collect research data with a total of four measurements during the application of the first, second, third and last protocols of chemotherapy.

Expected Results: As a result of the study, it is expected that Quran recitation will have a positive effect on quality of life and sleep in patients receiving chemotherapy due to breast cancer.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Breast Carcinoma Breast Diseases Breast Neoplasms Neoplasms Neoplasms by Site Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Having breast cancer
  • Being on chemotherapy
  • Being on a chemotherapy protocol every 21 days
  • Being over the age of 18
  • Not having communication problems
  • Being willing to participate in the study

Exclusion criteria

  • Having a hearing problem
  • Having an ear infection or any condition that prevents hearing
  • Having other types of cancer other than breast cancer

Treatment and study plan

Quran recital

Behavioral

standard treatment and care

Other names: standard treatment and care

standard treatment and care

Other

standard treatment and care

Primary outcomes

  1. The European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Scale (QLQ-C30), Version 3.0 (EORTC QLQ C-30)

    Time frame: From registration to the end of treatment at week 12

    The European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Scale (QLQ-C30), Version 3.0 (EORTC QLQ C-30) will be used to assess quality of life. High general well-being and functional subscale scores indicate high quality of life.

Secondary outcomes

  1. Pittsburg Sleep Quality Index

    Time frame: From registration to the end of treatment at week 12

    The Pittsburgh Sleep Quality Index (PSQI) was used to assess sleep quality. A score of six or above indicates poor sleep quality.

Study contacts

Contact information is provided by the study sponsor or research team.

Bedriye Cansu KOYUNOĞLU

CONTACT

[email protected]

+9005379652960

Derya ŞİMŞEKLİ

CONTACT

[email protected]

+9005545965789

Sponsors and collaborators

Lead sponsor

Ardahan University

Other

Collaborators

  • Erzurum Technical University

Registry information

Official study title

Effect of Quran Recital on Quality of Life and Quality of Sleep in Patients Receiving Chemotherapy Due to Breast Cancer

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Mar 25, 2025
Registry last updated
Mar 25, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.